Rentschler, CGT Catapult, and Refeyn Sign AAV Gene Therapy Agreement
Rentschler Biopharma agreed to collaborate with Cell and Gene Therapy Catapult and Refeyn to develop and apply novel process analytical technologies (PAT) to improve the...
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for the Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology
iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseasesManufacturing agreement supports advancement of...